Submacular Hemorrhage Associated With Retinal Arterial Macro Aneurysm

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02120066

Enrollment

Registered

2014-04-22

Start date

2011-01-31

Completion date

2014-04-30

Last updated

2014-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ruptured Retinal Arterial Macro Aneurysms, Submacular Hemorrhage

Keywords

Submacular hemorrhage, Vitrectomy, tissue- plasminogen activator

Brief summary

Evaluation of surgical outcome of vitrectomy with subretinal injection of recombinant tissue-plasminogen activator for submacular hemorrhage associated with retinal arterial macroanuerysms.

Interventions

PROCEDUREVitrectomy for submacular hemorrhage

DRUGsubretinal injection of tissue-plasminogen activator

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

40 Years to 95 Years

Healthy volunteers

Inclusion criteria

* The patients with sub macular hemorrhage associated with ruptured retinal arterial macro aneurysms

Exclusion criteria

* The eyes with preretinal or intraretinal hemorrhage at the fovea * The patients with follow-up less than 3 months

Design outcomes

Primary

Measure	Time frame	Description
Displacement of sub macular hemorrhage	one year	Anatomical recovery detected funduscopy and optical coherence tomography

Secondary

Measure	Time frame	Description
Visual acuity	one year	Visual recovery after surgery

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026